How much does Rucaparib cost?

Rucaparib (Rucaparib belongs to a class of drugs called poly(ADP-ribose) polymerase (PARP) inhibitors, which work by killing cancer cells. Rucaparib may be used to help maintain responses to other treatments for certain types of ovarian cancer (cancer that starts in the female reproductive organs, where eggs are formed), fallopian tubes (the tubes that carry eggs released from the ovaries to the uterus), and primary peritoneal (the layer of tissue that lines the abdomen) cancers that have come back in adults who have had a complete or partial response to other chemotherapy treatments.

Rucaparib is also used to treat certain types of ovarian, fallopian tube and primary peritoneal cancer in people with specific genes who have already received at least two other chemotherapy treatments. Rucaparib is also used to treat certain types of prostate cancer that have spread to other parts of the body in people with certain genes who have received other treatments. Common side effects of rucaparib include fatigue or weakness, nausea, vomiting, anemia, abdominal pain, dysgeusia, elevated levels of liver enzymes in the blood, decreased appetite, diarrhea, and thrombocytopenia.

The original drug Rucapani has not yet been marketed in the country, so it has not entered the medical insurance coverage standards. The European version of rucapani original drug, specifications300mg*60 tablets sold overseas may cost more than 20,000 yuan per box (the price may fluctuate due to exchange rate effects), which is relatively expensive. There are also cheaper generic rucapani drugs available overseas, and their pharmaceutical ingredients are basically the same as those of the original rucapani drug. For example, in India, the price of 300mg*60 tablets per box of BDR pharmaceuticals may be more than 6,000 yuan, and the price of 200mg*60 tablets per box may be more than 5,000 yuan (prices may fluctuate due to exchange rates).